Development and validation of the Immune Profile Score (IPS), a novel multi-omic algorithmic assay for stratifying outcomes in a real-world cohort of advanced solid cancer patients treated with immune checkpoint inhibitors

Alia Zander, Rossin Erbe, Yan Liu, Ailin Jin, Seung Won Hyun, Sayantoni Mukhopadhyay, Ben Terdich, Mario Rosasco, Nirali Patel, Brett Mahon, Kate Sasser, Michelle Ting-Lin, Halla Nimeiri, Justin Guinney, Douglas R. Adkins, Matthew Zibelman, Kyle A. Beauchamp, Chithra Sangli, Michelle M. Stein, Timothy Taxter, Timothy A. Chan, Sandip Pravin Patel, Ezra Cohen
doi: https://doi.org/10.1101/2024.11.05.24316583
Back to top
Posted November 05, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Development and validation of the Immune Profile Score (IPS), a novel multi-omic algorithmic assay for stratifying outcomes in a real-world cohort of advanced solid cancer patients treated with immune checkpoint inhibitors
Alia Zander, Rossin Erbe, Yan Liu, Ailin Jin, Seung Won Hyun, Sayantoni Mukhopadhyay, Ben Terdich, Mario Rosasco, Nirali Patel, Brett Mahon, Kate Sasser, Michelle Ting-Lin, Halla Nimeiri, Justin Guinney, Douglas R. Adkins, Matthew Zibelman, Kyle A. Beauchamp, Chithra Sangli, Michelle M. Stein, Timothy Taxter, Timothy A. Chan, Sandip Pravin Patel, Ezra Cohen
medRxiv 2024.11.05.24316583; doi: https://doi.org/10.1101/2024.11.05.24316583
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area